Emily defends her PhD thesis
Updated: Feb 7, 2021
Congratulations to Emily Cox who defended her PhD thesis on August 12, 2019! Her thesis focused on understanding and engineering monoclonal antibodies that preferentially recognize glycan structures. Specifically, Emily developed a "humanized" antibody against the cancer-associated oligosaccharide polysialic acid (polySia) and showed that it could be leveraged for possible therapeutic intervention by reformatting as a synthetic immunotherapy known as an antibody-drug conjugate (ADC). During her time at Cornell, Emily collaborated closely with the Alabi and Paszek labs on the topic of antibody-based targeting of the glycocalyx. Emily is now pursuing a position in the biopharmaceutical industry.